Investors Overview

Webcast ImageWebcast
Q2 2014 Bacterin International Holdings Inc Earnings Conference Call (Live)
08/13/14 at 10:00 a.m. ET
Q2 2014 Bacterin International Holdings Inc Earnings Conference Call
Wednesday, August 13, 2014 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$7.12
Change (%) Stock is Up 0.20 (2.89%)
Volume27,722
Data as of 07/31/14 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
07/31/14Bacterin Announces Public Offering of Common Stock
BELGRADE, Mont., July 31, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an effective shelf registration statement. Net proceeds from the offering are expected to be used for working capital and general corporate purpose... 
Printer Friendly Version
07/29/14Bacterin to Report Second Quarter 2014 Financial Results on August 12, 2014
BELGRADE, Mont., July 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended June 30, 2014, on August 12, 2014 at the close of the financial markets. An accompanying conference call hosted by Dan Goldberger, Chief Executive Officer and John Gandolfo, Chief Financial Officer, to disc... 
Printer Friendly Version
07/23/14Bacterin Announces Reverse Split of Common Stock
BELGRADE, Mont., July 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that a 1:10 reverse split of its common stock will be effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014. The reverse stock split was approved by the company's shareholders at the 2014 Annual Shareholder's... 
Printer Friendly Version
07/21/14Bacterin Announces Preliminary Second Quarter 2014 Results
Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year. BELGRADE, Mont., July 21, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary unaudited results for the second quarter of 2014. The Company is anticipating total net revenu... 
Printer Friendly Version
More

Upcoming Events
DateTitle
08/13/14 10:00 a.m. ET
Q2 2014 Bacterin International Holdings Inc Earnings Conference Call
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.